Jump to Navigation

Facebook Connect

User login

The Effects of Statin Therapy on Diabetes Incidence and Glycemic Control

The Effects of Statin Therapy on Diabetes Incidence and Glycemic Control


Schedule: On Demand (The original live program aired on May 16, 2012 8:00 PM EST)

Program Overview:
Statin treatment may be associated with adverse effects on glucose metabolism. Concerns have been raised regarding the effects of statin therapy on diabetes incidence and glycemic control. Join Drs. Spencer Kroll and Sergio Fazio as they discuss the current literature on statin therapy and the risks of developing diabetes. This live CME broadcast will provide you the opportunity to address your questions with the expert faculty.

Faculty:
William E. Boden, MD, FACC, FAHA
James M. Falko, MD, FACE, FACC, FNLA

Technical Support

This program requires a current version of ONE of the wollowing web browsers, with JavaScript enabled:

  • Google Chrome
  • Firefox 5.0 or greater
  • Safari
  • Internet Explorer 8.0 or greater

This NLA Lipid Insights Archive Program is Mobile Device friendly. If you experience difficulty viewing the video portion of this program, please contact us.

The handouts portion of this program requires the Adobe Acrobat Reader or a similar PDF program. You probably already have it; but if you cannot view the handouts, you can obtain the Adobe Acrobat Reader here.

If you require assistance to view/hear this program, please contact us.

4
Average: 4 (1 vote)

Education Information

This program, though not accredited in its archived form, is targeted towards specific content areas and learning objectives.



Content Domain
This activity falls under the following content domain(s):

  • 3.2.1 Diabetes Mellitus and other Insulin Resistant States

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Correctly indicate the frequency and secondary causes of statin intolerance and treatment options for statin-intolerant patients
  2. Discuss current literature regarding statin medications and the risks of developing diabetes.
  3. Evaluate the risks and benefits of worsening glycemic control in the context of improving lipid parameters



by Dr. Radut.